Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line

Blood

Volumn 87, Issue 12, 1996, Pages 5061-5073

  Hill, Stephen A ^a   Shaughnessy, Stephen G ^a   Joshua, Penny ^a   Ribau, Jose ^a   Austin, Richard C ^a   Podor, Thomas J ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; STREPTAVIDIN; VITRONECTIN; VON WILLEBRAND FACTOR;

ARTICLE; CELL VACUOLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; FLOW CYTOMETRY; GENE EXPRESSION; HEP 2 CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOPRECIPITATION; INTERNALIZATION; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TARGETING; SECRETORY GRANULE;

EID: 0029937109     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5061.bloodjournal87125061     Document Type: Article

References (69)

1. Preissner KT, Holzhüter S, Justus C, Müller-Bergbaus G: Identification and partial characterization of platelet vitronectin: Evidence of complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 74:1989, 1989
2. Declerck PJ, De Mol M, Alessi M-C, Baudner S, Paques E-P, Preissner KT, Muller-Berghaus G, Collen D: Purification and characterization of a plasminogen activator inhibitor-1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454, 1988
3. Wiman B, Almquist A, Sigurdardottir O, Lindahl, T: Plasminogen activator inhibitor-1 (PAI) is bound to vitronectin in plasma. FEBS Lett 242:125, 1988
4. Mimuro J, Loskutoff DJ: Purification of a protein from bovine plasma that binds to type-1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix - Evidence that the protein is vitronectin. J Biol Chem 264:936, 1989
5. Salonen E-M, Vaheri A, Pöllänen J, Stephens R, Andreasen P, Mayer M, Dano K, Gailit J, Ruoslahti E: Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 264:6339, 1989
6. Levi M, Biemond BJ, van Zonneveld A-J, ten Cate JW, Pannekoek J: Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 85:305, 1992
7. Serizawa K, Urano T, Kozima Y, Takada Y, Takada A: The potential role of platelet PAI-1 in t-PA-mediated clot lysis of platelet-rich plasma. Thromb Res 71:289, 1993
8. Braaten JV, Handt S, Jerome WG, Kirkpatrick J, Lewis JC, Hantgan RR: Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor -1: Light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus. Blood 81:1290, 1993
9. 2-antiplasmin and plasminogen activator inhibitor-1 (PAI-1) in the inhibition of clot lysis. Thromb Haemost 70:301, 1993
10. Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D: Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and independent mechanisms. Blood 83:351, 1994
11. Shohet RV, Spitzer S, Madison EL, Bassel-Duby R, Gething M-J, Sambrook JF: Inhibitor-resistant tissue-type plasminogen activator: An improved thrombolytic agent in vitro. Thromb Haemost 71:124, 1994
12. Stringer HAR, van Swieten P, Heijnen, HFG, Sixma JJ, Pannekoek H: Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Arterioscler Thromb 14:1452, 1994
13. Konkle BA, Schick PK, He X, Lui RJ, Mazur EM: Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288. Arterioscler Thromb 13:669, 1993
14. Alessi ML, Chomiki N, Berthier R, Schwietzer A, Fossat C, Juhan-Vague I: Detection of plasminogen activator inhibitor-1 (PAI-1) mRNA in human megakaryocytes by in situ hybridization. Thromb Haemost 72:931, 1994
15. George JN: Platelet immunoglobulin G: Its significance for the evaluation of thrombocytopenia and for understanding the origin of α-granule proteins. Blood 76:859, 1990
16. Greenberg SM, Rosenthal DS, Greeley TA, Tantravahi R, Handin RI: Characterization of a new megakaryocytic cell line: The Dami cell. Blood 72:1968, 1988
17. Hum BAL, Chantler SM: Production of reagent antibodies. Methods Enzymol 70:104, 1980
18. Seiffert D, Podor TJ: Immunological detection of conformational changes of type-1 plasminogen activator inhibitor associated with activation. Fibrinolysis 5:225, 1991
19. Lawrence D, Strandberg L, Grundstrom T, Ny T: Purification of active human plasminogen activator inhibitor-1 from E. coli: Comparison with natural and recombinant forms purified from eucaryotic cells. Eur J Biochem 186:523, 1989
20. Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD: cDNA cloning of human plasminogen activator inhibitor from endothelial cells. J Clin Invest 78:1673, 1986
21. Suzuki S, Oldberg A, Hayman EG, Pierschbacker MD, Ruoslahti E: Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 4:2519, 1985
22. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M: Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Function 13:281, 1988
23. Stockmann A, Hess S, Declerck P, Timpl R, Preissner KT: Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem 268:22874, 1993
24. Laemlli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 277:680, 1970
25. Seiffert D, Ciambroni G, Wagner NV, Binder BR, Loskutoff DJ: The somatomedin B domain of vitronectin. J Biol Chem 269:2659, 1994
26. Lafrenie RM, Podor TJ, Buchanan MR, Orr FW: Up-regulated biosynthesis and expression of endothelial cell vitronectin receptor enhances cancer cell adhesion. Cancer Res 52:2202, 1992
27. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB: Controlled synthesis of HbsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615, 1979
28. Kassis J, Hirsh J, Podor TJ: Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type 1 plasminogen activator inhibitor biosynthesis. Blood 80:1758, 1992
29. Newman GR: LR white embedding medium for colloidal gold methods, in Hayat MA (ed): Colloidal Gold: Principles, Methods, and Application, vol 2. London, UK, Academic, 1989, p 47
30. Hayward CPM, Bainton DF, Smith JW, Horsewood P, Stead RH, Podor TJ, Warkentin TE, Kelton JG: Multimerin is found in the α-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest 91:2630, 1993
31. Bonifacio JS: Metabolic labelling of cells, in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology, vol 2. New York, NY, John Wiley and Sons, 1991, p 10.18.1
32. Chomzynski P, Sacchi N: Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
33. Allen RW, Trach KA, Hoch JA: Identification of the 37 kDa protein displaying a variable interaction with the erythroid membrane as glyceraldehyde 3-phosphate dehydrogenase. J Biol Chem 262:649, 1987
34. Feinberg AP, Vogelstein BV: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
35. Podor TJ, Hirsh J, Gelehrter TD, Zeheb R, Torrey D, Guigoz Y, Gauldie J: Type-1 plasminogen activator inhibitor (PAI-1) is not an acute phase reactant in rats: Lack of interleukin-6 and hepatocyte dependent synthesis. J Immunol 150:225, 1993
36. Seiffert D, Geisterfer M, Gauldie J, Young E, Podor TJ: Interleukin-6 stimulates vitronectin gene expression in vivo. J Immunol 155:3180, 1995
37. Ginsburg D, Konkle BA, Gill JC, Montgomery RR, Bockenstedt PL, Johnson TA, Yang AY: Molecular basis of human von Willebrand disease: Analysis of platelet von Willebrand mRNA. Proc Natl Acad Sci USA 86:3723, 1989
38. Sottile J, Mosher DF, Fullenweider J, George JN: Human platelets contain mRNA transcripts for platelet factor IV and actin. Thromb Haemost 62:1100, 1989
39. Fava RA, Casey TT, Wilcox J, Pelton RW, Moses HL, Nanney LB: Synthesis of transforming growth factor-β1 by megakaryocytes and its localization to megakaryocytes and platelet α-granules. Blood 76:1946, 1990
40. Gambau L, Schleef RR: Processing of type-1 plasminogen activator inhibitor (PAI-1) into the regulated secretory pathway. J Biol Chem 269:3875, 1994
41. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR: Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 70:327, 1988
42. Gewirtz AM, Shapiro C, Shen YM, Boyd R, Coleman RW: Cellular and molecular regulation of factor V expression in human megakaryocytes. J Cell Physiol 153:277, 1992
43. Simpson AJ, Booth NA, Moore NR, Bennett B: The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br J Haematol 75:543, 1990
44. George JN, Saucerman S: Platelet IgG, IgA, IgM and albumin: Correlation of platelet and plasma concentrations in normal subjects and in patients with ITP or dysproteinemia. Blood 72:362, 1988
45. Gerrard JM, Phillips DR, Rao GHR, Plow EF, Wulz DA, Ross R, Harker LA, White SG: Biochemical studies of two patients with grey platelet syndrome: Selective deficiency of platelet alpha granules. J Clin Invest 66:102, 1980
46. Mosher DF, Presciotta DM, Loftus JC, Albrect RM: Secreted alpha proteins: The race for receptors, in George JN, Nurden AT, Phillips DR (eds): Platelet Membrane Glycoproteins. New York, NY, Plenum, 1988, p 171
47. Ginsberg MH, Forsyth J, Lightsey A, Chediak J, Plow EF: Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenia platelets. J Clin Invest 71:619,1983
48. Mosher DF: Fibronectin. Prog Hemost Thromb 5:111, 1980
49. Coller BS, Cheresh DA, Asch E, Seligsohn U: Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with glanzmann thrombasthenia in Israel. Blood 77:75, 1991
50. Tomiyama Y, Tsubakio T, Piotrowicz RS, Kurata Y, Loftus JC, Kunicki TJ: The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible for high-affinity macromolecules. Blood 79:2303, 1992
51. Thiagarajan P, Kelly KL: Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 263:3035, 1988
52. Asch E, Podack E: Vitronectin binds to activated human platelets and plays a role in platelet aggregation. J Clin Invest 85:1372, 1990
53. Morgenstern E, Ruf A, Patscheke H: Transport of anti-glycoprotein IIb/IIIa-antibodies into the alpha-granules of unstimulated human blood platelets. Thromb Haemost 67:121, 1992
54. Suzuki M, Kawakatsu T, Nagata H, Hamamoto K, Iwata K, Ohga S, Nomura S, Kokawa T, Yasunaga K: Effects of injected antibody against the platelet glycoprotein IIb/IIIa complex on monkey platelet fibronectin. Thromb Haemost 67:578, 1992
55. Wencel-Drake JD, Frelinger AD III, Dieter MG, Lam SC-T: Arg-Gly-Asp dependent occupancy of GP Iib/IIIa by applaggin: Evidence for internalization and cycling of a platelet integrin. Blood 81:62, 1993
56. Ying W, Waltz DA, Roa N, Drummond RJ, Rosenberg S, Chapman HA: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380, 1994
57. Seiffert D, Loskutoff D: Evidence that type 1 plasminogen activator inhibitor binds to the Somatomedin B domain of vitronectin. J Biol Chem 266:2824, 1991
58. Morris CA, Underwood PA, Bean PA, Sheehan M, Charlesworth JA: Relative topography of biologically active domains of human vitronectin. J Biol Chem 269:23845, 1994
59. Sigurdardottir O, Wiman B: Identification of a PAI-1 binding site on vitronectin. Biochim Biophys Acta 1208:104, 1994
60. 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin. J Biol Chem 268:11492, 1993
61. Panetti TS, McKeown-Longo PJ: Receptor-mediated endocytosis of vitronectin is regulated by its conformational state. J Biol Chem 268:11988, 1993
62. Völker W, Hess S, Visher P, Preissner KT: Binding and processing of multimeric vitronectin by vascular endothelial cells. J Histochem Cytochem 41:1823, 1993
63. 3 integrins in platelet protein trafficking. Blood 78:2603, 1991
64. Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoff DJ: Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci USA 88:9402, 1991
65. Podor TJ, Loskutoff DJ: Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor in the extracellular matrix of transforming growth factor-β activated endothelial cells. Ann NY Acad Sci 667:46, 1992
66. Schleef RR, Loskutoff DJ, Podor TJ: Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells. J Cell Biol 113:1413, 1991
67. Booth NA, Croll A, Bennett B: The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelets. Fibrinolysis 4:138, 1990
68. Owensby DA, Morton PA, Wun T-C, Schwartz AL: Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. J Biol Chem 266:4334, 1991
69. Seiffert D, Wagner NN, Loskutoff DJ: Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor. J Cell Biol 111:1283, 1990